Cavitary myiasis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:165958B87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Cavitary myiasis is a parasitic infestation caused by the larvae (maggots) of various fly species that invade natural body cavities, including the nasal passages, oral cavity, paranasal sinuses, ears, and urogenital tract. Unlike cutaneous myiasis, which affects the skin, cavitary myiasis involves deeper anatomical spaces and can lead to significant tissue destruction. The condition occurs when flies deposit their eggs or larvae in or near body openings, and the developing larvae feed on living or necrotic tissue within these cavities. Common causative species include Cochliomyia hominivorax (New World screwworm), Chrysomya bezziana (Old World screwworm), Oestrus ovis, and Wohlfahrtia magnifica, among others. Key symptoms depend on the body cavity affected but may include pain, foul-smelling discharge, bleeding, nasal obstruction, facial swelling, and in severe cases, destruction of cartilage and bone. Oral cavitary myiasis can present with swelling of the gums, palate, or lips with visible larvae. Aural (ear) myiasis may cause hearing loss, tinnitus, and secondary infection. Risk factors include poor hygiene, open wounds near body cavities, debilitated or bedridden patients, individuals with intellectual disabilities, those with oral breathing habits, and living in tropical or subtropical regions where causative fly species are endemic. Treatment involves mechanical removal of all larvae from the affected cavity, which may require endoscopic assistance depending on the location and depth of infestation. Debridement of necrotic tissue is often necessary. Topical application of substances such as chloroform, ether, or turpentine oil may be used to immobilize larvae before extraction. Systemic ivermectin has been used as an adjunctive treatment to kill remaining larvae. Antibiotics are prescribed to manage or prevent secondary bacterial infections. Surgical intervention may be required in cases with extensive tissue destruction. Prevention focuses on wound care, personal hygiene, and protection from fly exposure, particularly in vulnerable populations.

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Cavitary myiasis.

View clinical trials →

No actively recruiting trials found for Cavitary myiasis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Cavitary myiasis community →

No specialists are currently listed for Cavitary myiasis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Cavitary myiasis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Cavitary myiasisForum →

No community posts yet. Be the first to share your experience with Cavitary myiasis.

Start the conversation →

Latest news about Cavitary myiasis

No recent news articles for Cavitary myiasis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Cavitary myiasis

What is Cavitary myiasis?

Cavitary myiasis is a parasitic infestation caused by the larvae (maggots) of various fly species that invade natural body cavities, including the nasal passages, oral cavity, paranasal sinuses, ears, and urogenital tract. Unlike cutaneous myiasis, which affects the skin, cavitary myiasis involves deeper anatomical spaces and can lead to significant tissue destruction. The condition occurs when flies deposit their eggs or larvae in or near body openings, and the developing larvae feed on living or necrotic tissue within these cavities. Common causative species include Cochliomyia hominivorax (